| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00004502021 |
| 005 |
20191203131445.0 |
| 008 |
060220s2006 ne a b 001 0 eng |
| 016 |
7 |
|
|a 101266709
|2 DNLM
|
| 020 |
|
|
|a 0123976324 (alk. paper)
|
| 029 |
0 |
|
|a NLM
|b 101266709
|
| 035 |
|
|
|a (OCoLC)ocm65360708
|
| 035 |
|
|
|z (UtOrBLW)39940
|
| 035 |
|
|
|a 57546
|
| 040 |
|
|
|a NLM
|c NLM
|d TMV
|d UtOrBLW
|
| 042 |
|
|
|a nlmcopyc
|
| 049 |
|
|
|a TMVM
|c 1
|
| 060 |
0 |
0 |
|a 2006 B-351
|
| 060 |
1 |
0 |
|a WL 300
|b G32624 2006
|
| 060 |
|
4 |
|a WL 300
|b G3265 2006
|
| 245 |
0 |
0 |
|a Gene therapy in the central nervous system :
|b from bench to bedside /
|c [edited by] Michael G. Kaplitt and Matthew J. During.
|
| 264 |
|
1 |
|a Amsterdam ;
|a Boston :
|b Academic Press,
|c 2006.
|
| 300 |
|
|
|a xiv, 355 pages :
|b illustrations (some color) ;
|c 29 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Design and optimization of expression cassettes including promoter choice and regulatory elements -- Identification of novel adeno-associated virus serotypes for use of vectors -- HSV amplicon vectors for gene delivery to the nervous system -- Influence of immune system on central nervous system gene transfer -- Targeted induction of endogenous neural stem and progenitor cells : a new strategy for gene therapy of neurological disease -- Neurosurgical targeting, delivery and infusion of gene therapy agents in the brain -- Gene transfer for neurological disease : agencies, policies and process -- Gene therapy for Parkinson's disease -- Nonhuman primate models for testing gene therapy for neurodegenerative disorders -- Delivery of molecular therapeutics into the CNS and their distribution within the brain -- Gene therapy for CNS diseases using intrabodies -- Gene therapy for epilepsy -- Genetic manipulation of learning and memory -- Psychiatric applications of viral vectors -- Use of viral vectors to influence behavior -- Herpes simplex vector mediated gene transfer to the peripheral nervous system for the treatment of polyneuropathy and chronic pain -- Characteristics of pain receptors in the spinal cord using a viral vector for spatial-temporal gene targeting -- Viral vector mediated gene therapy of pain -- VEGE, an angiogenic factor with neurotrophic activity, useful for treatment of ALS -- Viral vector axonal uptake and retrograde transport : mechanisms and applications -- Gene therapy for spinal cord injury -- Prodrug-activation gene therapy -- Clinical trials of gene therapy for canavan disease -- Gene therapy for the late infantile form of batten disease -- Molecular imaging of gene therapy for neurogenetic diseases
|
| 650 |
|
2 |
|a Central Nervous System Diseases
|x therapy.
|
| 650 |
|
2 |
|a Genetic Therapy.
|
| 650 |
|
2 |
|a Central Nervous System Diseases
|x genetics.
|
| 650 |
|
2 |
|a Gene Transfer Techniques.
|
| 650 |
|
2 |
|a Genetic Vectors.
|
| 700 |
1 |
|
|a Kaplitt, Michael G.
|
| 700 |
1 |
|
|a During, Matthew J.
|
| 948 |
|
|
|a PO 10821; Blackwell
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 52cd5bf9-c90f-3e0b-8c31-cf5b74f1a6aa
|i 0164548f-f5d9-3831-b188-5cadc217a09f
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e WL 300 G3265 2006
|h National Library of Medicine classification
|i unmediated -- volume
|m 3238901905715
|
| 998 |
f |
f |
|a WL 300 G3265 2006
|t 0
|l Remote Storage
|